← All companies

Myriad

Technology

Company overview

Myriad is a genetic testing and genomic profiling company whose tests help detect health risks, guide treatment choices and prevent disease. MyRisk checks a person's risk of hereditary cancer. BRACAnalysis CDx tests genes linked to breast cancer. MyChoice CDx profiles tumors to help plan cancer treatment. Myriad is based in San Jose, California.

Myriad was founded in 1991 in Salt Lake City, Utah, by Mark Skolnick, Peter Meldrum and Kevin Kimberlin. It is a public company traded on Nasdaq under the ticker MYGN. In 2021 it had about 2,600 employees and revenue of $690.6 million. That means it operates as a public company focused fully on genetic testing science. Myriad is an H-1B sponsor.

Industry
Technology
Headquarters
San Jose, United States

Filters

Create your account

Create an account to save jobs and track applications.